These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12931562)

  • 41. Successful treatment of duodenal myeloid sarcoma with allogeneic bone marrow transplantation and additional radiotherapy.
    Yagi T; Ishikawa J; Takahashi M; Yamashita Y; Kusakabe S; Yoshinami T; Masaie H; Sugimoto N; Yoshida H; Imamura F
    Intern Med; 2012; 51(7):769-72. PubMed ID: 22466836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone Marrow Involvement in Unknown Acute Myeloid Leukemia Detected by 18F-FDG PET/MRI.
    Paone G; Stüssi G; Pons M; Giovanella L; Ceriani L
    Clin Nucl Med; 2015 Oct; 40(10):e486-7. PubMed ID: 26204209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffuse 18F-fluorodeoxyglucose accumulation in the bone marrow of a patient with haemophagocytic lymphohistiocytosis due to Hodgkin lymphoma.
    Harada S; Shinohara T; Naruse K; Machida H
    BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27793796
    [No Abstract]   [Full Text] [Related]  

  • 44. Value of detecting bone marrow involvement in Hodgkin lymphoma - Response to Adams and Kwee.
    Pedersen MA; Gormsen LC; d'Amore F
    Br J Haematol; 2019 Nov; 187(3):396-397. PubMed ID: 31483478
    [No Abstract]   [Full Text] [Related]  

  • 45. Classical Hodgkin's Lymphoma with Skeletal Muscle Involvement: A Testing Case.
    Baqari SAS; Razi M; Hayat J; Wali RM
    J Coll Physicians Surg Pak; 2019 Jan; 29(1):81-83. PubMed ID: 30630578
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Value of detecting bone marrow involvement in Hodgkin lymphoma.
    Adams HJA; Kwee TC
    Br J Haematol; 2019 Nov; 187(3):397-399. PubMed ID: 31524948
    [No Abstract]   [Full Text] [Related]  

  • 47. PET-MRI hybrid imaging in a rare case of B cell lymphoblastic lymphoma with musculoskeletal manifestation.
    Eichner R; Essler M; Specht K; Wörtler K; Peschel C; Bassermann F; Ringshausen I
    Ann Hematol; 2014 Mar; 93(3):501-3. PubMed ID: 23775582
    [No Abstract]   [Full Text] [Related]  

  • 48. Diffuse Hypermetabolic Bone Marrow Infiltration in Severe Primary Hyperoxaluria on FDG PET.
    Tonnelet D; Benali K; Rasmussen C; Goulenok T; Piekarski E
    Clin Nucl Med; 2020 Jun; 45(6):e296-e298. PubMed ID: 32366792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Picture in Clinical Hematology No. 106].
    Rinsho Ketsueki; 2017; 58(8):903. PubMed ID: 28883271
    [No Abstract]   [Full Text] [Related]  

  • 50. Bone marrow signal during PET imaging in Hodgkin lymphoma.
    Fyfe A; McKay P; Leach M
    Br J Haematol; 2010 Apr; 149(2):165. PubMed ID: 20015301
    [No Abstract]   [Full Text] [Related]  

  • 51. How I treat advanced classical Hodgkin lymphoma.
    Johnson P; McKenzie H
    Blood; 2015 Mar; 125(11):1717-23. PubMed ID: 25564404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow involvement in Q fever--detection by fluorine-18-labelled fluorodeoxyglucose PET.
    Alwis L; Balan K; Wright P; Lever A; Carmichael A
    Lancet Infect Dis; 2009 Nov; 9(11):718. PubMed ID: 19850230
    [No Abstract]   [Full Text] [Related]  

  • 53. Diffusely increased F-18 FDG uptake in bone marrow in a patient with acute anemia and recent erythropoietin therapy.
    Plantade A; Montravers F; Selle F; Izrael V; Talbot JN
    Clin Nucl Med; 2003 Sep; 28(9):771-2. PubMed ID: 12973005
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hodgkin lymphoma: protecting the victims of our success.
    Cheson BD
    J Clin Oncol; 2012 Dec; 30(36):4456-7. PubMed ID: 23150696
    [No Abstract]   [Full Text] [Related]  

  • 55. Bone marrow (reticuloendothelial system) scintigraphy for haematological follow-up of radiochemotherapy-treated patients.
    Esik O; Rajtár M; Naszály A
    Oncology; 1993; 50(4):298-302. PubMed ID: 8497381
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased bone marrow FDG uptake at PET/CT is not a sufficient proof of bone marrow involvement in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC
    Am J Hematol; 2015 Sep; 90(9):E182-3. PubMed ID: 26010072
    [No Abstract]   [Full Text] [Related]  

  • 57. [Allogeneic bone marrow transplantation in a patient with primary hepatic diffuse large B-cell lymphoma that relapsed after autologous stem cell transplantation].
    Ishiguro K; Hayashi T; Aoki Y; Maruyama Y; Ikeda H; Ishida T; Shinomura Y
    Nihon Shokakibyo Gakkai Zasshi; 2014 Sep; 111(9):1798-804. PubMed ID: 25195965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary hyperoxaluria type 1: appearance in FDG PET, bone- and bone marrow scintigraphy.
    Kadalie CT; Schreiner O; Kauczor HU; Bartenstein P
    Nuklearmedizin; 2003 Aug; 42(4):N37-9. PubMed ID: 15127719
    [No Abstract]   [Full Text] [Related]  

  • 59. Prolonged Myelosuppression due to Progressive Bone Marrow Fibrosis in a Patient with Acute Promyelocytic Leukemia.
    Inagawa Y; Komeno Y; Saito S; Maenohara Y; Yamagishi T; Kawashima H; Saito T; Abe K; Iihara K; Hatada Y; Ryu T
    Case Rep Hematol; 2019; 2019():1616237. PubMed ID: 31885950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma.
    Thummalapalli R; Sena LA; Probasco JC; Gladstone DE
    Leuk Lymphoma; 2020 Jan; 61(1):228-230. PubMed ID: 31502489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.